Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul;29(7):1139-1145.
doi: 10.1038/s41431-021-00862-5. Epub 2021 Apr 15.

Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2

Affiliations
Case Reports

Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2

James Whitworth et al. Eur J Hum Genet. 2021 Jul.

Abstract

Gastrointestinal stromal tumour (GIST) is a mesenchymal neoplasm arising in the gastrointestinal tract. A rare subset of GISTs are classified as wild-type GIST (wtGIST) and these are frequently associated with germline variants that affect the function of cancer predisposition genes such as the succinate dehydrogenase subunit genes (SDHA, SDHB, SDHC, SDHD) or NF1. However, despite this high heritability, familial clustering of wtGIST is extremely rare. Here, we report a mother-son diad who developed wtGIST at age 66 and 34 years, respectively. Comprehensive genetic testing revealed germline truncating variants in both SDHA (c.1534C>T (p.Arg512*)) and PALB2 (c.3113G>A (p.Trp1038*)) in both affected individuals. The mother also developed breast ductal carcinoma in-situ at age 70 years. Immunohistochemistry and molecular analysis of the wtGISTs revealed loss of SDHB expression and loss of the wild-type SDHA allele in tumour material. No allele loss was detected at PALB2 suggesting that wtGIST tumourigenesis was principally driven by succinate dehydrogenase deficiency. However, we speculate that the presence of multilocus inherited neoplasia alleles syndrome (MINAS) in this family might have contributed to the highly unusual occurrence of familial wtGIST. Systematic reporting of tumour risks and phenotypes in individuals with MINAS will facilitate the clinical interpretation of the significance of this diagnosis, which is becoming more frequent as strategies for genetic testing for hereditary cancer becomes more comprehensive.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Histology and SDHB immunohistochemistry on GIST samples from SDHA/PALB2 diad.
A, C Haematoxylin and eosin staining on samples from son and mother, respectively. B, D Loss of SDHB immunostaining on samples from son and mother, respectively. Non neoplastic cells show a retained mitochondrial staining pattern which can be appreciated in B and D.
Fig. 2
Fig. 2. Integrative genomics viewer screenshot from coordinate of SDHA variant.
BAM files resulting from sequencing DNA extracted from tumour. Loss of SDHA wild-type allele shown in samples from both members of diad as indicated by predominance of variant (denoted by red colour) bases.
Fig. 3
Fig. 3. Sanger sequencing chromatograms from coordinate of PALB2 variant resulting from sequencing DNA extracted from tumour.
Retention of wild-type allele indicated by dual peak at site of variant.

References

    1. Rammohan A, Sathyanesan J, Rajendran K, Pitchaimuthu A, Perumal S-K, Srinivasan U, et al. A gist of gastrointestinal stromal tumors: a review. World J Gastrointest Oncol. 2013;5:102–12. doi: 10.4251/wjgo.v5.i6.102. - DOI - PMC - PubMed
    1. Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CDM, et al. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Gr. J Clin Oncol. 2008;26:5360–7. doi: 10.1200/JCO.2008.17.4284. - DOI - PMC - PubMed
    1. Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, et al. Molecular Subtypes of KIT/PDGFRA Wild-Type gastrointestinal stromal tumors: a report from the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016;2:922–8. doi: 10.1001/jamaoncol.2016.0256. - DOI - PMC - PubMed
    1. Janeway KA, Kim SY, Lodish M, Nosé V, Rustin P, Gaal J, et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci USA. 2011;108:314–8. doi: 10.1073/pnas.1009199108. - DOI - PMC - PubMed
    1. Wang Y-M, Gu M-L, Ji F. Succinate dehydrogenase-deficient gastrointestinal stromal tumors. World J Gastroenterol. 2015;21:2303–14. doi: 10.3748/wjg.v21.i8.2303. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances